Abstract Immune checkpoint therapy in breast cancer remains restricted to triple negative patients, and long-term clinical benefit is rare. The primary aim of immune checkpoint blockade is to prevent or reverse exhausted T cell states, but T cell exhaustion in breast tumors is not well understood. H...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!